Chapter 5 Follicle Stimulating Hormone Receptor Mutations and Reproductive Disorders

Progress in Molecular Biology and Translational Science

Volumn 89, Issue C, 2009, Pages 115-131

  Tao, Ya Xiong ^a   Segaloff, Deborah L ^b  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Constitutively active mutation; Follicle stimulating hormone receptor; Infertility; Mutation; Spontaneous ovarian hyperstimulation syndrome

Indexed keywords

FOLLITROPIN RECEPTOR; MUTANT PROTEIN;

GENETICS; GONADAL DISEASE; HUMAN; METABOLISM; MUTATION; REPRODUCTION; REVIEW; STRUCTURE ACTIVITY RELATION;

GONADAL DISORDERS; HUMANS; MUTANT PROTEINS; MUTATION; RECEPTORS, FSH; REPRODUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77957040480     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)89005-4     Document Type: Review

References (95)

1. Pierce J.G., and Parsons T.F. Glycoprotein hormones: structure and function. Annu Rev Biochem 50 (1981) 465-495
2. Fares F.A., Suganuma N., Nishimori K., LaPolt P.S., Hsueh A.J., and Boime I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci USA 89 (1992) 4304-4308
3. Sugahara T., Sato A., Kudo M., Ben-Menahem D., Pixley M.R., Hsueh A.J., et al. Expression of biologically active fusion genes encoding the common alpha subunit and the follicle-stimulating hormone beta subunit. Role of a linker sequence. J Biol Chem 271 (1996) 10445-10448
4. Fox K.M., Dias J.A., and Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol Endocrinol 15 (2001) 378-389
5. Lapthorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J., et al. Crystal structure of human chorionic gonadotropin. Nature 369 (1994) 455-461
6. Oktay K., Briggs D., and Gosden R.G. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 82 (1997) 3748-3751
7. Parmentier M., Libert F., Maenhaut C., Lefort A., Gerard C., Perret J., et al. Molecular cloning of the thyrotropin receptor. Science 246 (1989) 1620-1622
8. McFarland K.C., Sprengel R., Phillips H.S., Kohler M., Rosemblit N., Nikolics K., et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 245 (1989) 494-499
9. Sprengel R., Braun T., Nikolics K., Segaloff D.L., and Seeburg P.H. The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 4 (1990) 525-530
10. Minegishi T., Nakamura K., Takakura Y., Ibuki Y., and Igarashi M. Cloning and sequencing of human FSH receptor cDNA. Biochem Biophys Res Commun 175 (1991) 1125-1130
11. Gromoll J., Gudermann T., and Nieschlag E. Molecular cloning of a truncated isoform of the human follicle stimulating hormone receptor. Biochem Biophys Res Commun 188 (1992) 1077-1083
12. Tilly J.L., Aihara T., Nishimori K., Jia X.C., Billig H., Kowalski K.I., et al. Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology 131 (1992) 799-806
13. Braun T., Schofield P.R., and Sprengel R. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 10 (1991) 1885-1890
14. Davis D., Liu X., and Segaloff D.L. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol 9 (1995) 159-170
15. Rousseau-Merck M.F., Atger M., Loosfelt H., Milgrom E., and Berger R. The chromosomal localization of the human follicle-stimulating hormone receptor gene (FSHR) on 2p21-p16 is similar to that of the luteinizing hormone receptor gene. Genomics 15 (1993) 222-224
16. Gromoll J., Ried T., Holtgreve-Grez H., Nieschlag E., and Gudermann T. Localization of the human FSH receptor to chromosome 2 p21 using a genomic probe comprising exon 10. J Mol Endocrinol 12 (1994) 265-271
17. Fan Q.R., and Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 (2005) 269-277
18. Fan Q.R., and Hendrickson W.A. Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol Cell Endocrinol 260-262 (2007) 73-82
19. Hipkin R.W., Liu X., and Ascoli M. Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem 270 (1995) 26683-26689
20. Donadeu F.X., and Ascoli M. The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology 146 (2005) 3907-3916
21. Thomas R.M., Nechamen C.A., Mazurkiewicz J.E., Muda M., Palmer S., and Dias J.A. Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology 148 (2007) 1987-1995
22. Tao Y.X., Johnson N.B., and Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 279 (2004) 5904-5914
23. Urizar E., Montanelli L., Loy T., Bonomi M., Swillens S., Gales C., et al. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24 (2005) 1954-1964
24. Guan R., Feng X., Wu X., Zhang M., Zhang X., Hebert T.E., et al. Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J Biol Chem 284 (2009) 7483-7494
25. Aittomaki K., Lucena J.L.D., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82 (1995) 959-968
26. Aittomaki K., Herva R., Stenman U., Kaisa J., Yiostalo P., and Hovatta Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle stimulating hormone receptor gene. J Clin Endocrinol Metab 81 (1996) 3722-3726
27. Simoni M., Gromoll J., and Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18 (1997) 739-773
28. Beau I., Touraine P., Meduri G., Gougeon A., Desroches A., Matuchansky C., et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 102 (1998) 1352-1359
29. Layman L.C., Amde S., Cohen D.P., Jin M., and Xie J. The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46, XX ovarian failure. Fertil Steril 69 (1998) 300-302
30. Touraine P., Beau I., Gougeon A., Meduri G., Desroches A., Pichard C., et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 13 (1999) 1844-1854
31. Gromoll J., Simoni M., Nordhoff V., Behre H.M., De Geyter C., and Nieschlag E. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 125 (1996) 177-182
32. Nakamura Y., Maekawa R., Yamagata Y., Tamura I., and Sugino N. A novel mutation in exon8 of the follicle-stimulating hormone receptor in a woman with primary amenorrhea. Gynecol Endocrinol 24 (2008) 708-712
33. Allen L.A., Achermann J.C., Pakarinen P., Kotlar T.J., Huhtaniemi I.T., Jameson J.L., et al. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod 18 (2003) 251-256
34. Doherty E., Pakarinen P., Tiitinen A., Kiilavuori A., Huhtaniemi I., Forrest S., et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 87 (2002) 1151-1155
35. Meduri G., Touraine P., Beau I., Lahuna O., Desroches A., Vacher-Lavenu M.C., et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J Clin Endocrinol Metab 88 (2003) 3491-3498
36. Tapanainen J.S., Aittomaki K., Min J., Vaskivuo T., and Huhtaniemi I.T. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 15 (1997) 205-206
37. Jaquette J., and Segaloff D.L. Temperature sensitivity of some mutants of the lutropin/choriogonadotropin receptor. Endocrinology 138 (1997) 85-91
38. Matthews C.H., Borgato S., Beck-Peccoz P., Adams M., Tone Y., Gambino G., et al. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet 5 (1993) 83-86
39. Layman L.C., Lee E.J., Peak D.B., Namnoum A.B., Vu K.V., van Lingen B.L., et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med 337 (1997) 607-611
40. Simoni M., Gromoll J., Hoppner W., Kamischke A., Krafft T., Stahle D., et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 84 (1999) 751-755
41. Ghadami M., Salama S.A., Khatoon N., Chilvers R., Nagamani M., Chedrese P.J., et al. Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. Mol Hum Reprod 14 (2008) 9-15
42. Rannikko A., Pakarinen P., Manna P.R., Beau I., Misrahi M., Aittomaki K., et al. Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. Mol Hum Reprod 8 (2002) 311-317
43. Tao Y.X., and Segaloff D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144 (2003) 4544-4551
44. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 239 (2005) 1-14
45. Tao Y.X. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol Ther 111 (2006) 949-973
46. Abell A.N., and Segaloff D.L. Evidence for the direct involvement of transmembrane region six of the lutropin/choriogonadotropin receptor in activating Gs. J Biol Chem 272 (1997) 14586-14591
47. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455 (2008) 497-502
48. Morello J.P., Salahpour A., Laperriere A., Bernier V., Arthus M.F., Lonergan M., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105 (2000) 887-895
49. Noorwez S.M., Kuksa V., Imanishi Y., Zhu L., Filipek S., Palczewski K., et al. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J Biol Chem 278 (2003) 14442-14450
50. Noorwez S.M., Malhotra R., McDowell J.H., Smith K.A., Krebs M.P., and Kaushal S. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J Biol Chem 279 (2004) 16278-16284
51. Janovick J.A., Maya-Nunez G., and Conn P.M. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J Clin Endocrinol Metab 87 (2002) 3255-3262
52. Janovick J.A., Goulet M., Bush E., Greer J., Wettlaufer D.G., and Conn P.M. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor. J Pharmacol Exp Ther 305 (2003) 608-614
53. Fan Z.C., and Tao Y.X. Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. J Cell Mol Med (2009) 10.1111/j.1582-4934.2009.00726.x [in press]
54. Chaipatikul V., Erickson-Herbrandson L.J., Loh H.H., and Law P.Y. Rescuing the traffic-deficient mutants of rat μ-opioid receptors with hydrophobic ligands. Mol Pharmacol 64 (2003) 32-41
55. Petaja-Repo U.E., Hogue M., Bhalla S., Laperriere A., Morello J.P., and Bouvier M. Ligands act as pharmacological chaperones and increase the efficiency of δ opioid receptor maturation. EMBO J 21 (2002) 1628-1637
56. Fan J., Perry S.J., Gao Y., Schwarz D.A., and Maki R.A. A point mutation in the human melanin concentrating hormone receptor 1 reveals an important domain for cellular trafficking. Mol Endocrinol 19 (2005) 2579-2590
57. Van Craenenbroeck K., Clark S.D., Cox M.J., Oak J.N., Liu F., and Van Tol H.H. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J Biol Chem 280 (2005) 19350-19357
58. Robert J., Auzan C., Ventura M.A., and Clauser E. Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone. J Biol Chem 280 (2005) 42198-42206
59. Hawtin S.R. Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor. J Biol Chem 281 (2006) 14604-14614
60. Fortin J.P., Dziadulewicz E.K., Gera L., and Marceau F. A nonpeptide antagonist reveals a highly glycosylated state of the rabbit kinin B1 receptor. Mol Pharmacol 69 (2006) 1146-1157
61. Bernier V., Morello J.P., Zarruk A., Debrand N., Salahpour A., Lonergan M., et al. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17 (2006) 232-243
62. Janovick J.A., Maya-Nunez G., Ulloa-Aguirre A., Huhtaniemi I.T., Dias J.A., Verbost P., et al. Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine. Mol Cell Endocrinol 298 (2009) 84-88
63. van Straten N.C., Schoonus-Gerritsma G.G., van Someren R.G., Draaijer J., Adang A.E., Timmers C.M., et al. The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction. ChemBioChem 3 (2002) 1023-1026
64. Jaschke H., Neumann S., Moore S., Thomas C.J., Colson A.O., Costanzi S., et al. A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J Biol Chem 281 (2006) 9841-9844
65. Fuller P.J., Verity K., Shen Y., Mamers P., Jobling T., and Burger H.G. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 83 (1998) 274-279
66. Ligtenberg M.J., Siers M., Themmen A.P., Hanselaar T.G., Willemsen W., and Brunner H.G. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J Clin Endocrinol Metab 84 (1999) 2233-2234
67. Latronico A., and Segaloff D. Naturally occurring mutations of the luteinizing hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 65 (1999) 949-958
68. Giacaglia L.R., Kohek M.BDF., Carvalho F.M., Fragoso M.C., Mendonca B., and Latronico A.C. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors. Fertil Steril 74 (2000) 992-995
69. Gromoll J., Simoni M., and Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hyophysectomized man. J Clin Endocrinol Metab 81 (1996) 1367-1370
70. Schaison G., Young J., Pholsena M., Nahoul K., and Couzinet B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 77 (1993) 1545-1549
71. Ballesteros J.A., and Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci (1995) 366-428
72. Vasseur C., Rodien P., Beau I., Desroches A., Gerard C., de Poncheville L., et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349 (2003) 753-759
73. Smits G., Olatunbosun O., Delbaere A., Pierson R., Vassart G., and Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 349 (2003) 760-766
74. Montanelli L., Delbaere A., Di Carlo C., Nappi C., Smits G., Vassart G., et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 89 (2004) 1255-1258
75. Montanelli L., Van Durme J.J., Smits G., Bonomi M., Rodien P., Devor E.J., et al. Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Mol Endocrinol 18 (2004) 2061-2073
76. De Leener A., Montanelli L., Van Durme J., Chae H., Smits G., Vassart G., et al. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab 91 (2006) 555-562
77. Rodien P., Bremont C., Sanson M.L., Parma J., Van Sande J., Costagliola S., et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339 (1998) 1823-1826
78. De Leener A., Caltabiano G., Erkan S., Idil M., Vassart G., Pardo L., et al. Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome. Hum Mutat 29 (2008) 91-98
79. Zhang M., Tao Y.X., Ryan G.L., Feng X., Fanelli F., and Segaloff D.L. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations. J Biol Chem 282 (2007) 25527-25539
80. Vassart G., Pardo L., and Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29 (2004) 119-126
81. Caltabiano G., Campillo M., De Leener A., Smits G., Vassart G., Costagliola S., et al. The specificity of binding of glycoprotein hormones to their receptors. Cell Mol Life Sci 65 (2008) 2484-2492
82. Daelemans C., Smits G., de Maertelaer V., Costagliola S., Englert Y., Vassart G., et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 89 (2004) 6310-6315
83. Hershman J.M. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid 9 (1999) 653-657
84. Check J.H., Choe J.K., and Nazari A. Hyperreactio luteinalis despite the absence of a corpus luteum and suppressed serum follicle stimulating concentrations in a triplet pregnancy. Hum Reprod 15 (2000) 1043-1045
85. Ryan G.L., Feng X., d'Alva C.B., Zhang M., Van Voorhis B.J., Pinto E.M., et al. Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with severe juvenile primary hypothyroidism. J Clin Endocrinol Metab 92 (2007) 2312-2317
86. Kudo M., Osuga Y., Kobilka B.K., and Hsueh A.J.W. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem 271 (1996) 22470-22478
87. Latronico A.C., Abell A.N., Arnhold I.J.P., Liu X., Lins T.S.S., Brito V.N., et al. A unique constitutively activating mutation in the third transmembrane helix of the luteinizing hormone receptor causes sporadic male gonadotropin independent precocious puberty. J Clin Endocrinol Metab 83 (1998) 2435-2440
88. Tao Y.X., Abell A.N., Liu X., Nakamura K., and Segaloff D.L. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III. Mol Endocrinol 14 (2000) 1272-1282
89. Tao Y.X., Mizrachi D., and Segaloff D.L. Chimeras of the rat and human FSH receptors (FSHRs) identify residues that permit or suppress transmembrane 6 mutation-induced constitutive activation of the FSHR via rearrangements of hydrophobic interactions between helices 6 and 7. Mol Endocrinol 16 (2002) 1881-1892
90. Tao Y.X. Constitutive activation of G protein-coupled receptors and diseases: insights into mechanism of activation and therapeutics. Pharmacol Ther 120 (2008) 129-148
91. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21 (2000) 90-113
92. Angelova K., Fanelli F., and Puett D. A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J Biol Chem 277 (2002) 32202-32213
93. 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276 (2001) 29171-29177
94. 1b-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol Pharmacol 61 (2002) 1025-1032
95. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., and Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454 (2008) 183-187